• Dr.Sejal Kuchhadia
• Dr. D. B. Vaghela

Hearing loss or hearing impairment is a partial or entire inability to hear. It can result in hearing conversational speech or loud sounds with difficulty. It can be unilateral or bilateral. As Badhirya is impaired hearing, it can be compared with Deafness (Hearing Loss). Defect at any level from sound transduction to interpretation can cause hearing loss. According to modern science, there are mainly three types of deafness. 1) Conductive Deafness 2) Sensory Neural Deafness and 3) Mixed Deafness. Vata Dosha Pradhana Badhirya can be corresponded with Sensory Neural Hearing Loss. Here in present study Bilwadi Taila Karnapurana is used and it comes under the external Snehana. Generally medicated oil is used for Karnapurana as Taila is having virtue of Vata Shamana but do not aggravate Kapha. In addition, medicine is used as Luke warm, so it has beneficial effect not only on Vata but also removes Avarana of Kapha. Apakva Bilwa Phala exhibits Ushna Virya and Vata-Kaphahara property. Bhavaprakasha Nighantu mentions that Bilwa exhibits action on nerves and hence is considered as Nadi Balya (give strength to nerves). Thus, it is inferred that Bilwa is helping in nourishment of the ear cells as well as regeneration of damaged cells in deafness. The drugs used in Shadabindu Taila and Sarivadi Vati are Bruhaniya in nature. It also helps in stabilizing the Prakupita Vata-Kapha Dosha by its virtue of action and in preventing retrogressive changes in Vruddhavastha. Hence the treatment is planned by the taking the Bilwadi Taila Karnapurana, Shadabindu Taila Nasya and Sarivadi Vati orally as the drug of choice. Materials and Methods: total 30 patients were divided into two groups by open labelled computerized randomized comparative clinical trial with group A- Bilwadi Taila Karnapurana, Sarivadi Vati orally and Shadabindu Taila Nasya and with Group B Bilwadi Taila Karnapurana and Sarivadi Vati orally. Result and Discussion: In Group A, 33.33% patients got cured, 46.66% patients got marked improvement, 13.33% patients got moderate improvement, none of the patients got mild improvement and 6.66% patient remained unchanged and in Group B, 13.33% of patients got cured, 6.66% of patients got marked improvement, 20% got mild improvement, 33.33% patients got moderate improvement and 26.66% patients remained unchanged.

Badhirya, Bilwadi Taila, Sarivadi Vati, Shadabindu Taila, SNHL.

"EFFICACY OF BILWADI TAILA KARNAPURANA AND SARIVADI VATI WITH AND WITHOUT SHADABINDU TAILA NASYA IN THE MANAGEMENT OF BADHIRYA (SENSORY NEURAL HEARING LOSS) - AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 7, page no.f25-f39, July-2022, Available :http://www.jetir.org/papers/JETIR2207504.pdf

"EFFICACY OF BILWADI TAILA KARNAPURANA AND SARIVADI VATI WITH AND WITHOUT SHADABINDU TAILA NASYA IN THE MANAGEMENT OF BADHIRYA (SENSORY NEURAL HEARING LOSS) - AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 7, page no. ppf25-f39, July-2022, Available at : http://www.jetir.org/papers/JETIR2207504.pdf